| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/17/2003 | US20030073686 Anticarcinogenic agents |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073670 Aqueous solution |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | US20030073581 Spraying on plants, environment |
| 04/17/2003 | CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | CA2462875A1 Allylamides useful in the treatment of alzheimer's disease |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462861A1 Piperidine compounds as muscarinic antagonists |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302463A1 Medicine comprising dicyanopyridine derivative |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1301787A2 Method for detecting uracil biosynthesis inhibitors and their use as herbicides |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301506A1 Cyclic amino acid derivatives |
| 04/16/2003 | EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 04/16/2003 | EP1301487A2 Viral polymerase inhibitors |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP1301481A1 Pyrrole derivatives for treating aids |
| 04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 04/16/2003 | EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 04/16/2003 | EP1240159A4 Improved omeprazole process and compositions thereof |
| 04/16/2003 | EP1181017B1 Metalloprotease inhibitors |
| 04/16/2003 | EP1163224B1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance |
| 04/16/2003 | EP0991644B1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 04/16/2003 | EP0880508B1 Quinazoline derivatives as vegf inhibitors |
| 04/16/2003 | EP0787724B1 Novel intermediate for production and process for producing pyridine derivative |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411457A Substituted pyrroles |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411442A Farnesyl transferase inhibitors |
| 04/16/2003 | CN1411441A Farnesyl protein transferase inhibitors |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1411375A Use of bioactive metabolites of gepirone for treatment of psychological disorders |
| 04/16/2003 | CN1411374A Substituted piperazine and piperidine calcium channel blockers |
| 04/16/2003 | CN1410420A Process for preparing alkanosulfuryl pyridine |
| 04/16/2003 | CN1105716C Benzimidazole derivatives with antihistaminic activity |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/16/2003 | CN1105711C 嘧啶衍生物 Pyrimidine derivatives |
| 04/16/2003 | CN1105707C Pyrazole derivative |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548663 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 04/15/2003 | US6548548 Cardiovascular disorders; anticholesterol agents |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548525 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors |
| 04/15/2003 | US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548519 Pyridoxine and pyridoxal analogues: novel uses |
| 04/15/2003 | US6548517 Oxindole inhibitors of factor Xa |
| 04/15/2003 | US6548516 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/15/2003 | US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles |
| 04/15/2003 | US6548293 Enzymatic process for the resolution of enantiomeric mixtures of β-lactams |
| 04/15/2003 | CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| 04/15/2003 | CA2103665C Oligopeptide antiretroviral agents |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/11/2003 | WO2004096982A2 Antibacterial agents |
| 04/11/2003 | WO2002034724A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses |
| 04/10/2003 | WO2003029363A1 Water-color ink |
| 04/10/2003 | WO2003029359A1 Cationic reactive dyes |
| 04/10/2003 | WO2003029247A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | WO2003029246A1 Process for producing pyrimidone acetamide derivative and crystals thereof |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029244A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 04/10/2003 | WO2003029243A2 2-aryloxy-6-pyrazolyl-pyridines |
| 04/10/2003 | WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029222A1 Insecticidal and acaricidal 3-substituted pyrazoles |
| 04/10/2003 | WO2003029221A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists |
| 04/10/2003 | WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands |
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |